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Abstract 
 
Home treatment of Chronic Obstructive Pulmonary Disease (COPD) by a remote monitoring system can prevent progression of 
patient's illness and hospital admission due exacerbations. This paper presents the development of a COPD management system 
module to be integrated into the already existing product - OneCare Sensing, a platform able to monitor remotely biomedical 
parameters and/or vital signs, promoting an Ambient Assisted Living (AAL) ecosystem for patients in the comfort of their homes. 
Its aims is to provide a reliable and an effective system, helping patients and healthcare providers to control the COPD progress 
and prevent potential risk situations through alert and event settings.  
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1. Introduction and Objectives 
Average life expectancy has been growing worldwide the last decades. In Europe the average age will move from 
38 in 2004 to 49 years in 2050 [1]. We also observe an increasing of chronic diseases on population; according to 
WHO1, chronic diseases are the leading cause of mortality around the world, representing 60% of all deaths [2]. In 
this way, we can attribute at least part of the healthcare’s systems overload to the increasing demand by an older and 
more chronically sick population. Chronic diseases are among the most common and costly health problems, but they 
are also among the most preventable and can be effectively controlled. For this reason, health-care authorities are 
encouraging the promotion of the self-management, delivering the responsibility of controlling and managing the 
disease to the patient or to the healthcare provider. Monitoring and remote care solutions to manage patient’s chronic 
diseases using telecommunication technology are being widely implemented with special attention to computer-aided 
assistance. 
Monitoring of COPD’s patients with new technology is part of the solution to diminish its symptoms and focus on 
empowering people with age related dependencies or disabilities to live independently, delay or avoid 
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institutionalisation and staying active as much and as long as possible. In four New England hospitals, in-home 
management of congestive heart failure has reduced rehospitalizations for heart failure by 72% and all cardiac-related 
hospitalizations by 63% [3]. Thus, personal health home management of acute exacerbations of COPD may relieve 
pressure on acute care facilities and improve patient’s well-being. As an example, there is AERIAL’s mobile 
application [4] that is enable to collect respiratory values and predict exacerbations, based on a Baysean network; or 
the system developed by VitalMobile Health [5] to monitoring COPD patients through pulse-oximetry values and 
assisted ventilation. None of these systems provides all capabilities of our solution, since the former does not 
implement GOLD guidelines and its sensors are not totally portable and the second do not include spirometry data. 
The purpose of this study is to develop and integrate a new module into OneCare Sensing platform to monitor 
patients with COPD: OneCareTablet Spiro. The medical team of the Pneumologist service of Idealmed Private 
Hospital2 and ISA Intellicare3 team have participated on definition of requirements and specifications of this COPD 
monitoring system. A Proof of Concept will be also performed to validate the needs of patients and healthcare 
professionals to manage and control the disease. It will take place on Idealmed Private Hospital and in an early stage 
there will be given one kit (include a Tablet, a spirometer and an oximeter) for each 3 COPD’s patients that accepted 
to participated in this pilot study. An important feature is to test the usability of the application for the type of users 
of the system. 
2. Chronic Obstructive Pulmonary Disease 
COPD is a chronic pulmonary disease that has not a cure, but is preventable and treatable. It is characterized by 
airflow limitation that is not fully reversible and by inflammatory disorders with higher incidence in males in mid-life 
or later. Nowadays, COPD is one of the main causes of chronic mortality and morbidity and it is expected to reach in 
2030 the 4th place of the most deadly diseases much due the increase of tobacco consuming.  
Risk factors contribute for a faster decline of the pulmonary capacity, obstructing airways and raise the number 
and the degree of symptoms such as dyspnoea, chronic cough or sputum production. These side effects bring several 
functionally limitations and have a high impact on patients day-to-day routine.  
COPD coexists with other diseases like cardiovascular disease, osteoporosis, serious infections, presence of 
diabetes, lung cancer and it may have impact on patient’s prognosis. Exacerbations are important events in the course 
of the disease, because they negatively affect patient’s quality of life, accelerates the rate of decline of lung function, 
are associated with significant mortality and have high socioeconomic costs. The number of exacerbations enhance 
with the progress of the disease causing more visits to hospitals and healthcare providers [6]. 
3. OneCare Sensing and General Architecture 
OneCare Sensing is a system to continuously monitor biomedical values at home. It has an Android application 
(it is written in Dalvik and compiled to run without JVM) for Tablet and smartphones that receives the measurements 
from medical wireless devices as blood pressure monitors, scales and glucometers by Bluetooth and send them to the 
OneCare servers (Fig. 1). It allows the possibility for the healthcare professionals to monitor patient’s state of health 
at distance and provides assistance whenever any relevant changes occur. Measurements are available in the OneCare 
portal to be consulted by the patient, families or by healthcare provider [7].  
4. Added Value 
This project aims to integrate a new module, OneCareTablet Spiro, in OneCare Sensing to monitor COPD patients 
in a completely portable way. It must allow patients to have their values monitored from home, work place or other 
place they wish, allowing a quicker intervention of the healthcare providers with the reduction of the number of acute 
events. Thus, prevention, early detection and prompt treatment of exacerbations are vital to reduce the burden of 
COPD. To cover this lack, calculate the GOLD classification (a worldwide classification metric for disease status of 
patients with COPD), detect important changes in the patient status and send the information to the OneCare Sensing 
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Fig. 1: OneCare Sensing schematic [7]. 
 
To the healthcare responsible is crucial to maintain COPD patients stable and they can manage this by accessing 
to patient’s data on the web portal, allowing an on-time intervention and triggering a feedback action to the patient. 
The COPD monitoring solution will send notifications to healthcare responsible every time monitoring values fall 
from a certain level, increasing the ability to respond to rapid changes in the health status of patients. Besides the 
existing graphs, there will be a new intuitive option for the visualization of the data by the healthcare responsible: 
GOLD’s classification presented in Fig. 2 with patient’s grade highlighted (Supervise COPD). 
The airway obstruction can be easily identified during the expiration, therefore in COPD’s expiratory flows are 
changed. According to GOLD, Spirometry is a test to measure the amount of air a person can breathe out, the amount 
of time to do so and it is required to make a clinical diagnosis of COPD. In the presence of post-bronchodilator, if the 
value of FEV1/FVC is below 70% and the value of FEV1 is below 80% of the predictive values, confirms the presence 
of persistent airflow limitation and thus of COPD [8]. 
However, the goals of COPD assessment are to determine the severity of the disease, its impact on patient’s health 
status and the risk of future events such as exacerbations, hospital admissions or even death and prescribe the right 
therapy. Studies like the one conducted by Gary Parkes [9] show that only assessing the degree of airflow limitation 
using spirometry is not enough. In addition, it is need to collect data from the patient's quality of life and from the 
respiratory crises historical data. To bring this information together, GOLD produced a combined assessment of 
COPD, Fig 2. For further information on COPD see e.g. the Global Initiative for Chronic Obstructive Lung Disease 
(GOLD) [6]. 
As said on literature and recommendations for COPD management, spirometry is the most reliable, robust and 
objective method to determine lung capacity, providing numeric measurements with physiological and clinical 
meanings. There are other methods to diagnose a patient COPD such as respiratory sounds, chest x-rays or CT scan, 
but they are not easily reproduced at patient’s home or work. So, to design this system to monitor COPD patients, the 
choice fell on integrate a portable spirometer in OneCare Sensing.  
An evaluation process of spirometers available in marketplace was made based on PECA (Plan Evaluate Collect 
Analyse) process and was chosen the Vitalograph’s spirometer COPD-6 (Fig.5a), the product COTS evaluated with 
higher classification. Although, instead of measuring the value of FVC, it measures FEV6, it was found that, for 
portable lung monitors, this respiratory value is highly correlated with FVC and it is even more reproducible than the 
FVC, according to F.W. Rosa [10]. 
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After a patient has been diagnosed with COPD, it will need an effective COPD management plan: access and
monitor disease, reduce risk factors, manage stable COPD and manage exacerbations. This project will include these 
components, except the second one. Each component has its own requirements to perform it well, so our solution 
includes one monitoring option for each component: Full, GOLD and Simple monitor. It should be noted that not all 
COPD’s patients have the need to perform a full monitoring.
Fig. 3: Biomedical values for COPD monitoring.
Fig. 2: Combined Assessment of COPD [8].
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The patient execute different tests and measurements according to the selected type of COPD monitoring, having 
the possibility to collect values from the Spirometry Exam, oxygen level and heart rate from Pulse-Oximetry, 
symptoms from the answer to questionnaires and historical data by introducing the number of crisis patient had over 
the last year, as in Fig 3.  
Given what is said in norm “Diagnose and COPD Treatment”, patients with FEV1 value below 50% of the 
predictive value may be considered to perform pulse oximetry test [11]. Then, if the level of oxygen saturation in the 
blood is below 92%, the patient is indicated to visit the hospital. So, the application will check the biomedical values 
measured by the full or simple monitoring options for these conditions and send a notification to the healthcare 
responsible if needed. The same procedure is applied to GOLD monitor, “Manage stable disease” module, that for 
each time the system get valid parameters allowing the determination of the GOLD classification and if this 
classification decreases one level since the last GOLD monitoring, it will also send a notification to the healthcare 
provider. 
5. OneCareTablet Espiro: First results 
To date, the application covers the implementation of Simple Monitoring (Fig.4). After performing some tests, the 
application’s life cycle has performing well since selection of the monitoring option (Fig.4a) to the send of 
measurements to server (Fig.4b) and posterior visualization on OneCare portal (Fig.5b)), so it is already possible for 
who accessed patient's account to follow his COPD status.  
Given the fact that each monitoring option is a sequence of interfaces, after COPD monitoring parameters be 
collected, it is presented to patients a summary for they decide if measurements can be sent to server or, for some 
reason (a bad performing test, e.g), they have to be rejected. 
However, it was detected some issues during the communication to the external devices between the screen of 
spirometry acquisition values and oximetry acquisition screen: once it takes an amount of time that does not help 
usability of this COPD monitoring system mainly by elderly patients. We plan to improve this situation by providing 
more clear instructions for patients do not giving up on their monitoring plan. 
 
 
 
Fig. 4: a) COPD’s monitoring type screen b) Spirometry test acquisition values screen. 
6. Conclusion and future work 
This monitoring system especially designed for COPD patients seems to be promising. OneCare Tablet Spiro is 
innovative and extremely wanted by patients and health care professionals in order to decrease the negative impact of 
this chronic disease. It must be user-friendly to promote the attendance of patients in the system and increase their feel 
of security on it, because typically they do not feel comfortable with this technology due to their age. 
Now that the either the spirometer and pulse-oximeter have been integrated, we will continue to develop the other 
monitoring types (Full and Gold) with the integration of the questionnaires as well as a health alerts notification 
system, inasmuch as the part of the interface for manual data collection of parameters has been done and automatic 
acquisition through external devices too. 
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The development of this system is still ongoing, thus there are still no notifications alerts and the GOLD 
classification of patients to show. 
 
 
 
 
 
Fig. 5: a) Vitalograph’s COPD-6 spirometer b) Measurements visualization on OneCare Sensing portal.. 
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